Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep175 | Endocrine tumours and neoplasia | ECE2017

Follow-up in neuroendocrine tumors: is chromogranin A the confounder?

Martins Diana , Baptista Carla , Velez Ana , Macario Fernando , Carrilho Francisco

Introduction: Chromogranin A continues to be one of the most valuable markers for neuroendocrine tumors (NETs) however, it has several limitations, including its reduced specificity.Methods: The authors present the case of a patient diagnosed with a midgut NET, during follow-up.Results: Male patient, 61 years old, with chronic renal disease (CRD), underwent right hemicolectomy owing to ileo-cecal valve lesion; hist...

ea0049ep401 | Developmental endocrinology | ECE2017

Nutritional status in ambulatory patients by Medicine Laboratory

De La Torre Francisco Javier Merida , Bel Pena Nieves

Nutritional status has an important effect on the progression of any disease, not only in hospitalized patients, even more in ambulatory patient of primary care. Although there are many systems of evaluating nutritional status, they are costly and subject to variability amongst individuals. The Medicine Laboratory can correctly perform a nutritional evaluation in a quick an efficient manner.Objective: Analyze the nutritional status by CONUT nutritional e...

ea0049ep1295 | Thyroid (non-cancer) | ECE2017

Treatment of toxic multinodular goiter with 131 radioactive iodine – effects in volume reduction, thyroid function and autoimmunity

Roque Catarina , Sousa Santos Francisco , Pilli Tania , Pacini Furio

Abstract: Radioiodine is a definite treatment option for toxic goiter. We have evaluated volume reduction, function and autoimmunity outcomes with a 15 mCi fixed regimen. Patients with at least one US evaluation before and after Iodine-131 therapy and with at least one year of follow-up were included. TSH, free-T4, antibodies and goiter volume before and yearly after Iodine-131 treatment were analysed for the length of the entire follow-up. The total 151 patients, 72.6% female...

ea0041ep501 | Diabetes complications | ECE2016

Observational and retrospective study to analyze the changes in lipid and glycemic profiles in patients with metabolic syndrome after treatment with statins: ESMET study

del Canizo-Gomez Francisco Javier , Guinea-Lopez Rosario

The diabetogenic risk associated with statin therapy is higher in patients with pre-existing risk factors, such as metabolic syndrome (MS).Objective: To assess changes in lipid and glycemic profile in dyslipidemic subjects with MS after statin therapy.Methods: Observational, retrospective, multi-center study, conducted in 40 endocrinology Spanish hospitals. Each endocrinologist included the first 10 patients >18 years with MS, ...

ea0035p182 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014

Evaluation of lipid levels in familial hypercholesterolemia in a lipid unit

Gonzalez-Molero Inmaculada , Vallejo Rosario , Omiste Antonio , Tinahones Francisco

Objective: To determine the degree of control of hypercholesterolemia in a specific lipid unit.Material and Methods: Retrospective study of patients followed in our unit over the past 16 years diagnosed with heterozygous familial hypercholesterolemia (HFH) or familial combined hyperlipidemia (FCH). Control criteria according to the following recommendations were compared: International Panel (2003), Nice (2008), NLA (2011), ESC / ESA 2011, Consensus ADA ...

ea0035p647 | Female reproduction | ECE2014

A sensitive method for estrogen profiling in human serum by liquid chromatography–tandem mass spectrometry

Triebner Kai , Bifulco Ersilia , Real Francisco , Hustad Steinar

Estrogens are important for the development of the adult female phenotype and are intracellular mediators of androgen effects in many tissues. Measuring several estrogenic compounds in blood or other body fluids may be helpful for the assessment of estrogen status. Liquid chromatography–tandem mass spectrometry (LC–MS/MS) is a versatile technique, which allows for the measurement of conjugated and unconjugated steroids in a single sample volume without derivatization...

ea0070aep631 | Pituitary and Neuroendocrinology | ECE2020

Functional panhypopituitarism of anorexia

Roque Catarina , Sousa Santos Francisco , Sequeira Duarte João

A 30-year-old male was admitted to the neurotraumatology ward after head trauma with cerebral concussion, subdural & subarachnoidal haemorrhage. The Endocrinologist was called to evaluate high urinary debits. The patient was healthy until 4 years before admission. He enrolled on variate patterns of alimentary restriction that resulted in the loss of 28 kg. Since then he had visited multiple doctors (Cardiology, Haemathology, Psychiatry, Gastroenterology, Urology, Endocrino...

ea0032p220 | Clinical case reports – Pituitary/Adrenal | ECE2013

Adequate timing for adrenalectomy in pheochromocytoma multisystem crisis: can early biochemical diagnosis be the key?

Cayon Manuel , Garcia-Figueras Carolina , Gil Anselmo , Mateos Francisco

Introduction: Pheochromocytoma multisystem crisis (PMC) is the most fulminant clinical expression of pheochromocytoma. The appropriate timing and judgment for the start of surgery and the adequate preoperative medical treatment are unclear. We report a case of PMC successfully treated with elective adrenalectomy after doxazosin blockade. The importance of an early biochemical diagnosis is discussed.Case report: A 47-year-old healthy man consulted for sud...

ea0029p667 | Diabetes | ICEECE2012

Cardiorespiratory fitness is decreased and not correlated with C-Reactive Protein levels in adults with Diabetes Mellitus

Francisco C. , Catai A. , Moura S. , Lopes S. , Del Vale A. , Leal A.

Diabetes Mellitus (DM) has been associated with lung dysfunction and impairment of cardiorespiratory fitness and increasing evidences have suggested that comorbidities and systemic inflammation may be involved in these derangements. However, the results regarding cardiopulmonary dysfunction and its underlying mechanisms in DM are still controversial. In this study, we evaluated the relationship between metabolic variables and inflammation marker, including hemoglobin A1C (HbA1...

ea0016p179 | Diabetes and cardiovascular diseases | ECE2008

Degree of control of cardiovascular risk factors (CRFs) in patients with type 2 diabetes mellitus (T2DM) stratified by diabetes therapy

Javier del Canizo-Gomez Francisco , Moreira-Andres Maria Natividad

Control of CRFs in T2DM patients results in a clinically important reduction in the risk of death and complications related to diabetes.Objective: To assess the degree of control of modifiable CRFs in treated T2DM patients, stratified by diabetes therapy.Materials and methods: Cross-sectional study in 574 T2DM patients who attended our clinic for a routine follow-up. Fasting plasma glucose (FPG), HbA1C, HDL-Cholesterol (HDL-Ch), LD...